IP Library Patent Application 17457420
Patent Application
App. No. 17/457,420

METHOD FOR TREATING ASTHMA

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/457,420
Abstract

The present invention is directed to a method for treating Asthma. The method comprises administering to a subject in need thereof 3-methanesulfonylpropionitrile (dapansutrile), or a pharmaceutically acceptable solvate thereof, in an effective amount. The preferred route of administration is oral administration or local administration.

Claims (7)

1 . A method for treating asthma, comprising the step of:

administering dapansutrile or a pharmaceutically acceptable solvate thereof, to a subject in need thereof, in an amount effective to treat asthma.

2 . The method according to claim 1 , which reduces airway inflammation, reduces airway hyperresponsiveness, improves lung function, and/or reducing the symptoms of asthma.

3 . The method according to claim 1 , wherein said compound is administered by oral administration.

4 . The method according to claim 3 , wherein said compound is administered at a dosage of 500-4000 mg/day.

5 . The method according to claim 1 , wherein the treating is a therapeutic treatment, and dapansutrile is administered to the subject when the subject shows clinical signs and/or symptoms of asthma.

6 . The method according to claim 1 , wherein the treating is a prophylactic treatment, and dapansutrile is administered to the subject before the onset of asthma.

Assignments (1)
CHANGE OF NAME Recorded Nov 7, 2023
From: OLATEC THERAPEUTICS LLC
To: OLATEC THERAPEUTICS, INC.
Reel/Frame 065489/0809 →